Logitech M235 Wireless Mouse is a wireless device that connects to your laptop or computer wirelessly. With Plug-n-Play feature, this mouse can be connected with your device without even installing the software. The Logitech M235 is also compatible with Logitech Unifying Receiver that is powerful enough to wirelessly connect up to 6 computer peripherals. The M235 Mouse has a wireless range of 10 m or 33 feet thus allows you to relax on your couch or bed while using your laptop or a desktop. You can now purchase the Logitech mouse from Snapdeal and avail 3 years of Logitech India warranty.
Contoured Design
With soft cushiony side grips and comfortable shape for hands, the Logitech M235 Wireless Mouse looks elegant and offers relaxed usage for long hours. Play games or draft your PPT presentation, it is ideal for various purposes.
1-Year Battery Life
Keep using your mouse for an year without the worry to change the battery because the mouse comes with an on/off switch, which puts the mouse on sleep mode to extend the life of the battery. Additionally, it has an indicator light, which displays if the battery is getting weak and demands a change or not.
Logitech� Advanced Optical Tracking
Logitech M235 Wireless Mouse comes with Logitech Advanced Optical Tracking which offers smooth usage even in rough surface, where other mice stop working.
Logitech Reliability
Experience quality and trust together with Logitech M235, which comes with 3 years of hardware warranty.
Logitech Unifying Receiver
The receiver is universal which can work with any compatible wireless mouse or keyboard, eliminating the requirement of multiple USB receivers.
Click here to buy Logitech Wireless Mouse M235 Black for Rs.399
More from miscw.com
EGGDROP Spurs Global Marketing with Diverse K-content Collaboration
Elliptic Labs Signs New Contract with Existing Smartphone Customer
NEC and Red Hat Expand Global Collaboration to Drive IT Modernization and Digital Transformation
Revelation Biosciences Inc. Completes Dosing of Five Single Dose Cohorts and Receives Approval to Initiate a Multiple Dose Cohort to Phase 1 Clinical Study of REVTx-99, an Experimental Treatment for Respiratory Viral Infection, Including COVID-19
